DAP-4 Activators
DAP-4 Activators are a group of chemical compounds that significantly enhance the functional activity of DAP-4 (PRKRIR), primarily through distinct signaling pathways or biological processes. Among these activators, Phorbol 12-Myristate 13-Acetate (PMA) stands out as a direct activator of DAP-4. PMA binds to and activates protein kinase C (PKC), initiating PKC-dependent signaling pathways. This activation has a profound influence on various cellular processes under the regulatory control of PKC, thereby enhancing DAP-4-mediated functions. Another notable category of activators includes those that indirectly impact DAP-4 activity through the activation of Protein Kinase A (PKA). Compounds like forskolin elevate intracellular cAMP levels, subsequently activating PKA. PKA activation leads to the phosphorylation of PRKRIR, ultimately modulating its role in various cellular functions. Calcium Ionophore A23187 is another indirect activator that elevates intracellular calcium levels, activating PRKRIR and influencing cellular processes governed by calcium-dependent signaling pathways. Together, these DAP-4 Activators play a critical role in enhancing the functional activity of DAP-4 and influencing cellular functions through specific signaling pathways.
Additionally, Diacylglycerol (DAG) indirectly enhances DAP-4 activity by stimulating protein kinase C (PKC), which phosphorylates PRKRIR. Epinephrine indirectly impacts DAP-4 by binding to adrenergic receptors, activating adenylate cyclase, and increasing cAMP levels. Thrombin indirectly influences DAP-4 by activating PLCβ, generating inositol trisphosphate (IP3) and diacylglycerol (DAG), which modulate calcium signaling and PKC activity. Neomycin indirectly activates DAP-4 by inhibiting IP3 degradation, leading to enhanced calcium release through IP3 receptors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) directly activates DAP-4 by binding to and activating protein kinase C (PKC). This activation stimulates PRKRIR, influencing cellular processes through PKC-dependent signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 indirectly enhances DAP-4 activity by increasing intracellular calcium levels. Elevated calcium activates PRKRIR, influencing cellular processes governed by calcium-dependent signaling pathways. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DAG indirectly activates DAP-4 by stimulating protein kinase C (PKC), which subsequently phosphorylates PRKRIR. This activation influences cellular functions associated with PKC-mediated signaling pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine indirectly enhances DAP-4 activity by binding to adrenergic receptors, activating adenylate cyclase, and increasing cAMP levels. Elevated cAMP levels activate PKA, phosphorylating PRKRIR and affecting cellular processes regulated by PKA-dependent pathways. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $235.00 | ||
Thrombin indirectly enhances DAP-4 activity by binding to its receptors and activating PLCβ, generating inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 and DAG modulate calcium signaling and PKC activity, ultimately impacting PRKRIR-mediated cellular functions. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Neomycin indirectly activates DAP-4 by inhibiting IP3 degradation. By blocking IP3 dephosphorylation, neomycin increases IP3 levels, leading to enhanced calcium release through IP3 receptors and influencing PRKRIR-mediated cellular functions governed by calcium signaling. | ||||||
Xestospongin C | 88903-69-9 | sc-201505 | 50 µg | $510.00 | 14 | |
Xestospongin C indirectly activates DAP-4 by inhibiting IP3 receptor function, reducing calcium release from intracellular stores. This inhibition influences PRKRIR-mediated cellular processes associated with calcium release from stores. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine is a direct activator of DAP-4, targeting ryanodine receptors and resulting in calcium release from intracellular stores. This activation enhances PRKRIR-mediated cellular functions associated with calcium signaling pathways. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
Carbachol indirectly activates DAP-4 by stimulating muscarinic acetylcholine receptors, which activate PLCβ and generate IP3 and DAG. IP3 and DAG modulate calcium signaling and PKC activity, impacting PRKRIR-mediated cellular processes governed by these pathways. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene indirectly activates DAP-4 by inhibiting ryanodine receptors, reducing calcium release from intracellular stores. This inhibition influences PRKRIR-mediated cellular functions associated with ryanodine receptor activity. | ||||||